Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droperidol + granisetron versus dexamethasone + granisetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy
IRCT20141209020258N202Phase 3Recruiting
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Granisetron and Droperidol Group, Granisetron and Dexamethasone Group and Granisetron and Saline Group (3 arms). Primary endpoints: Nausea, Vomiting and 1 more. Started Apr 2026; status: recruiting.
02
Drugs
granisetrondroperidoldexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20141209020258N202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N202.